Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 5315 Posts
1 2 3 ... 333
Aphria Committee Finds LATAM Asset Acquisition Cost Within 'Acceptable Range'
Article By: The Fly
Friday, February 15, 2019 9:16 AM EST
Aphria announced that its board of directors has accepted and considered the report of the special committee of independent directors.
In this article: APHA
GlaxoSmithKline: The Next Portfolio Vaccine?
Article By: The Dividend Guy
Thursday, February 14, 2019 3:01 PM EST
The current stock price is considered overpriced for the value an investor would get in return. Dividends are satisfying, but there are no growth promises in the foreseeable future.
In this article: GSK
Is Gilead Science A Potential Buy?
Article By: Andreas Gruener
Thursday, February 14, 2019 4:19 AM EST
Currently, the company pays a yearly dividend of 2.52 USD, which equals a yield of 3.85%.
In this article: GILD
DBV Jumps 41% To $9.96 After Update On Viaskin Peanut Filing
Article By: The Fly
Wednesday, February 13, 2019 5:49 PM EST
Shares of DBV Technologies jumped after the company said that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut is anticipated in the third quarter of 2019.
In this article: DBVT Also: AIMT
5 Tiny Biotech Stocks With Superb Growth Potential
Article By: Swarup Gupta
Wednesday, February 13, 2019 11:40 AM EST
After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.
FV Pot Stocks: Who Has The Best Earnings Chart?
Video By: Tracey Ryniec
Tuesday, February 12, 2019 3:05 PM EST
Here are 5 pot stocks that are already publicly traded in the United States. Some have earnings track records, some do not.
In this video: ACB, CGC, CRON, TLRY, IIPR
Canaccord Says Sell NuVasive On Deal Speculation Rally, Buy Smith & Nephew
Article By: The Fly
Monday, February 11, 2019 3:00 PM EST
The analyst does not find a potential of NuVasive acquisition by Smith & Nephew "to be compelling". A deal could be disruptive to Smith & Nephew's turnaround in both commercial performance and investor sentiment.
In this article: NUVA, SNN
Vanda Pharmaceuticals Under Pressure As Aurelius Value Discloses Short Position
Article By: The Fly
Monday, February 11, 2019 11:40 AM EST
In morning trading, shares of Vanda Pharmaceutical have dropped over 5% to $17.98.
In this article: VNDA
Will Q4 Results Continue To Fuel Momentum In Marijuana ETF?
Article By: Sweta Killa
Saturday, February 9, 2019 4:31 PM EST
Aurora Cannabis, Canopy Growth, Cronos Group, and Tilray are expected to report results over the coming weeks. These stocks are the top four holdings in the marijuana ETF’s basket with a combined 39.4% share.
In this article: MJ, CGC, CRON, TLRY, ACB
The Amazing Retail Cannabis Boom
Article By: Adam Sharp
Saturday, February 9, 2019 9:48 AM EST
There’s never been a market like this before. It’s going to be a wild ride for the next few years, but those who buy and hold high-quality companies should do incredibly well.
In this article: TLRY, ACB
Marijuana ETF Joins Billion Dollar Club
Article By: Sweta Killa
Thursday, February 7, 2019 5:22 PM EST
The ETFMG Alternative Harvest ETF has now accumulated billion dollars in AUM since its inception in less than 14 months. It has soared 38.9% so far this year.
In this article: MJ Also: CRON, CG, MO
3 Cannabis Oil Leaders Investors Need To Know
Article By: Technical420
Tuesday, February 5, 2019 9:07 PM EST
We have been favorable on the cannabis oil opportunity and believe that this is an area where investors need to be focused. Here are 3 companies that are laser-focused on this burgeoning market.
In this article: MLCPF, AGEEF, RDDTF Also: ACB, HMPPF
Amyris Soars 48% After Announcing $255M Cannabinoid Partnership
Article By: The Fly
Tuesday, February 5, 2019 11:35 AM EST
Shares of Amyris have soared 48%, or $1.50, to $4.66 in morning trading.
In this article: AMRS
Becton, Dickinson Q1 Earnings In Line With Estimates
Article By: Zacks Investment Research
Tuesday, February 5, 2019 10:29 AM EST
Becton, Dickinson and Company posted first-quarter fiscal 2019 earnings per share of $2.70.
In this article: BDX Also: VAR, ANGO, CNMD
5 Marijuana Stock Gainers Monday
Article By: The Daily Marijuana Observer
Monday, February 4, 2019 10:57 PM EST
Here are some of the marijuana stock winners in trading Monday, by percentage change at least.
In this article: APHA, EMHTF, KSHB, LHSIF, MJARF
A Canopy Growth Stock Forecast For 2019
Article By: Taki Tsaklanos
Monday, February 4, 2019 5:47 PM EST
During the sell-off in the last 3 months of last year, we did spot something quite unusual: relative strength of cannabis stock in general, and Canopy Growth in particular.
In this article: CGC
1 to 16 of 5315 Posts
1 2 3 ... 333